Trial intelligence / Profile preview

Influenza VLP Vaccine in Healthy Adults

NCT00754455Phase 2Completed

Sponsor
Novavax
Start
Sep 2008
Primary completion
Mar 2009
Modality
Nanoparticles, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of influenza VLP vaccine in influenza, sponsored by Novavax. Started Sep 2008; status: completed.

02

Drugs

influenza VLP vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00754455.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00754455.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call